India  

Third dose of Covaxin gets nod for trials, six months after 2nd shot

Indian Express Thursday, 1 April 2021
0
shares
ShareTweetSavePostSend
 

You Might Like


Related news from verified sources

Covid-19: Government's expert panel allows clinical trials for third dose of Covaxin

Bharat Biotech presented amendments to the subject expert committee of the Drugs Controller General of India (DCGI) in the approved Phase 2 clinical trial...
IndiaTimes